FDA Orange Book · active-ingredient family
Idoxuridine
Idoxuridine is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:DENDRID · NDA 014169
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · ointment, solution/drops
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DENDRIDRLD | ALCON | NDA 014169 | — | Approved Prior to Jan 1, 1982 | |
| STOXIL | GLAXOSMITHKLINE | NDA 015868 | — | Approved Prior to Jan 1, 1982 | |
| HERPLEX | ALLERGAN | NDA 013935 | — | Approved Prior to Jan 1, 1982 | |
| STOXIL | GLAXOSMITHKLINE | NDA 013934 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Idoxuridine — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

